Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Operating Leases: 2019-2025

Historic Operating Leases for Veracyte (VCYT) over the last 7 years, with Sep 2025 value amounting to $40.5 million.

  • Veracyte's Operating Leases rose 105.41% to $40.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year increase of 105.41%. This contributed to the annual value of $43.2 million for FY2024, which is 474.58% up from last year.
  • Latest data reveals that Veracyte reported Operating Leases of $40.5 million as of Q3 2025, which was down 20.13% from $50.6 million recorded in Q2 2025.
  • Veracyte's 5-year Operating Leases high stood at $50.6 million for Q2 2025, and its period low was $7.5 million during Q4 2023.
  • Moreover, its 3-year median value for Operating Leases was $19.7 million (2024), whereas its average is $26.3 million.
  • In the last 5 years, Veracyte's Operating Leases dropped by 29.33% in 2023 and then soared by 474.58% in 2024.
  • Quarterly analysis of 5 years shows Veracyte's Operating Leases stood at $14.1 million in 2021, then fell by 24.46% to $10.6 million in 2022, then fell by 29.33% to $7.5 million in 2023, then surged by 474.58% to $43.2 million in 2024, then soared by 105.41% to $40.5 million in 2025.
  • Its last three reported values are $40.5 million in Q3 2025, $50.6 million for Q2 2025, and $50.5 million during Q1 2025.